Next-generation prostate cancer biobanking: Toward a processing protocol amenable for the international cancer genome consortium

Diagnostic Molecular Pathology

Volumn 21, Issue 2, 2012, Pages 61-68

  Esgueva, Raquel ^a   Park, Kyung ^a   Kim, Robert ^a   Kitabayashi, Naoki ^a   Barbieri, Christopher E ^a   Dorsey, Philip J ^b   Abraham, Cyril ^a   Banerjee, Samprit ^a   Leung, Robert A ^a   Tewari, Ashutosh K ^a   Terry, Stéphane ^a   Shevchuk, Maria M ^a   Rickman, David S ^a   Rubin, Mark A ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

next generation sequencing; prostate cancer biobanking; The Cancer Genome Atlas Program

Indexed keywords

EOSIN; HEMATOXYLIN; PARAFFIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CLINICAL PROTOCOL; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DNA EXTRACTION; EMBEDDING; FEASIBILITY STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOBANKING PROTOCOL; PROSTATE CANCER; PROSTATECTOMY; QUALITY CONTROL; RNA EXTRACTION; RNA SEQUENCE;

ADULT; AGED; AGED, 80 AND OVER; DNA; GENES, NEOPLASM; GENOME, HUMAN; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RNA; SEQUENCE ANALYSIS, RNA; SPECIMEN HANDLING; TISSUE BANKS;

EID: 84861233447     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e31823b6da6     Document Type: Article

References (31)

1. Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010. CA Cancer J Clin. 2010;60:277-300.
2. Andriole GL, Crawford ED, Grubb RL III, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009;360:1310-1319.
3. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:1320-1328.
4. Berger MF, Lawrence MS, Demichelis F, et al. The genomic complexity of primary human prostate cancer. Nature. 2011;470:214-220.
5. Pflueger D, Terry S, Sboner A, et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2011;21:56-67.
6. Sboner A, Habegger L, Pflueger D, et al. FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNAsequencing data. Genome Biol. 2010;11:R104.
7. Hollenbeck BK, Bassily N, Wei JT, et al. Whole mounted radical prostatectomy specimens do not increase detection of adverse pathological features. J Urol. 2000;164:1583-1586.
8. Dhir R. Prostate cancer biobanking. Curr Opin Urol. 2008;18: 309-314. (Pubitemid 351489382)
9. Menon M, Tewari A, Peabody J. Vattikuti institute prostatectomy: technique. J Urol. 2003;169:2289-2292. (Pubitemid 36576774)
10. Tewari A, Peabody J, Sarle R, et al. Technique of da Vinci robotassisted anatomic radical prostatectomy. Urology. 2002;60:569-572. (Pubitemid 35246433)
11. Tewari AK, Patel ND, Leung RA, et al. Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients. BJU Int. 2010;106:528-536.
12. Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2009;8:113-117.
13. Yau C, Holmes CC. CNV discovery using SNP genotyping arrays. Cytogenet Genome Res. 2008;123:307-312.
14. Kim K, Pak PJ, Ro JY, et al. Limited sampling of radical prostatectomy specimens with excellent preservation of prognostic parameters of prostate cancer. Arch Pathol Lab Med. 2009;133: 1278-1284.
15. Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56:899-905.
16. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011; 474:609-615.
17. Dhanasekaran SM, Barrette TR, Ghosh D, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412: 822-826. (Pubitemid 32801464)
18. Grossfeld GD, Chang JJ, Broering JM, et al. Does the completeness of prostate sampling predict outcome for patients undergoing radical prostatectomy?: data from the CAPSURE database. Urology. 2000;56:430-435. (Pubitemid 30658173)
19. Desai A, Wu H, Sun L, et al. Complete embedding and close stepsectioning of radical prostatectomy specimens both increase detection of extra-prostatic extension, and correlate with increased disease-free survival by stage of prostate cancer patients. Prostate Cancer Prostatic Dis. 2002;5:212-218.
20. Salem S, Chang SS, Clark PE, et al. Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: pathological outcomes and risk of biochemical recurrence. J Urol. 2010;184:1334-1340.
21. Bova GS, Fox WM, Epstein JI. Methods of radical prostatectomy specimen processing: a novel technique for harvesting fresh prostatecancer tissue and review of processing techniques. Mod Pathol. 1993;6:201-207.
22. Cohen MB, Soloway MS, Murphy WM. Sampling of radical prostatectomy specimens. How much is adequate? Am J Clin Pathol. 1994;101:250-252. (Pubitemid 24089565)
23. Haggman M, Norberg M, de la Torre M, et al. Characterization of localized prostatic cancer: distribution, grading and pT-staging in radical prostatectomy specimens. Scand J Urol Nephrol. 1993;27: 7-13. (Pubitemid 23107391)
24. Hall GS, Kramer CE, Epstein JI. Evaluation of radical prostatectomy specimens. A comparative analysis of sampling methods. Am J Surg Pathol. 1992;16:315-324.
25. Jhavar SG, Fisher C, Jackson A, et al. Processing of radical prostatectomy specimens for correlation of data from histopathological, molecular biological, and radiological studies: a new whole organ technique. J Clin Pathol. 2005;58:504-508. (Pubitemid 40646871)
26. Morrison C, Cheney R, Johnson CS, et al. Central quadrant procurement of radical prostatectomy specimens. Prostate. 2009;69:770-773.
27. Riddick AC, Barker C, Sheriffs I, et al. Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int. 2003;91:315- 323; discussion 23-24. (Pubitemid 36359633)
28. Sehdev AE, Pan CC, Epstein JI. Comparative analysis of sampling methods for grossing radical prostatectomy specimens performed for nonpalpable (stage T1c) prostatic adenocarcinoma. Hum Pathol. 2001;32:494-499. (Pubitemid 32506519)
29. Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648. (Pubitemid 41528150)
30. Salami SS, Schmidt F, Laxman B, et al. Combining urinary detection of TMPRSS2: ERG and CaP3 with serum PSA to predict diagnosis of prostate cancer. Urol Oncol. 2011. [Epub ahead of print].
31. Laxman B, Morris DS, Yu J, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostatecancer. Cancer Res. 2008;68:645-649. (Pubitemid 351206738)